Form 4 for BSX Boston Scientific
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-21 · accession 0001225208-24-002707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-21 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $66.35 | -4,960 | 72.6K | -6% | -$329.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | S | D | 4,960 | $66.35 | 72,604 | D | — | — |